IP Library Granted Patent US 10,583,037
Granted Patent B2
US 10,583,037 · App. 14/106,198 · Granted Mar 10, 2020

Heating device using exothermic chemical reaction

Inventors: Jonathan Isserow (Basking Ridge, NJ); Laura Isserow (Basking Ridge, NJ)
Assignee: TRANSQTRONICS, LLC.
A61F7/034A61B5/1491A61B5/4836A61B5/683A61F7/007A61F7/03A61N1/0452A61N1/0456A61N1/0492A61N1/36021A61N5/0616A61B5/0022A61B5/01A61B5/145A61B5/14507A61F2007/0052A61F2007/0071A61F2007/0078A61F2007/0093A61F2007/0094A61F2007/0226A61F2007/0234A61F2007/0236A61F2007/0261A61N5/062A61N5/0624A61N2005/0645A61N2005/0647
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,583,037
App. No.
14/106,198
Granted
Mar 10, 2020
Kind
B2
Abstract

The current invention discloses a treatment device having a heat source, a power source, a heat applicator and a lighting mechanism. The power source includes at least one battery having superior properties such as prolonged electricity production and prompt recharging. The heat applicator includes a heat conductive layer made from nanofibers, providing highly efficient heat distribution to the targeted regions. The lighting mechanism employs light emitting nano fibers to treat targeted regions. The power source provides energy to the light source, which generates light so that the applicator may distribute to an injury site or wound bed of a user. The heat source may be an exothermic chemical reaction designed to last for several hours supplying heat to the treatment device or an electronically produced heat. The treatment device further comprises a plurality of electrodes for electrical stimulation treatment.

Claims (46)

1. A treatment device comprising:

a therapeutic medium,

wherein the therapeutic medium is configured to produce temperatures covering a range of about −10° C. to about 50° C.;

an applicator connected to the therapeutic medium; the applicator comprising,

an application layer having an application surface and a receiving surface with the application layer being configured to be applied to a skin surface of a user, and a conductive layer having a front side and a back side,

wherein the conductive layer is directly affixed to and completely covers the receiving surface of the application layer, and

wherein the heat application layer has an adhesive material disposed on a portion of the application surface;

a power source connected to the treatment device, empowering a plurality of flexible lighting mechanisms,

wherein the power source is at least one battery;

a plurality of flexible electrodes integrated with the application layer,

wherein the plurality of flexible electrodes are coupled to the power source providing a mechanism for neuromuscular stimulation in a range of 1 Hz to 160 Hz, and

wherein the plurality of flexible electrodes are comprised of a flexible, conductive polymer;

the plurality of flexible lighting mechanisms being interwoven with fibers of the application layer,

wherein the plurality of flexible lighting mechanisms are configured to emit at least one of red wavelength light and blue wavelength light, and

wherein the plurality of flexible lighting mechanisms have a quantum efficiency of 0.65 to 0.95; and

a control mechanism for changing an operative state of the plurality of flexible lighting mechanisms.

2. The treatment device of claim 1 wherein the treatment device is a cutaneous patch with a low tack adhesive.

3. The treatment device of claim 1 wherein the plurality of flexible electrodes comprises at least one metal or metal alloy.

4. The treatment device of claim 1 , wherein the treatment device comprises temperature sensitive fibers.

5. The treatment device of claim 1 wherein the plurality of flexible electrodes are employed in any combination and sequence in conjunction with at least one other functionality of the treatment device such as heating, lighting, drug delivery, or any combination thereof.

6. The treatment device of claim 1 wherein the device is a garment, covering, or the like for establishing and maintenance of normothermia, hypothermia, or hyperthermia as required.

7. The treatment device of claim 1 wherein the conductive layer comprises conductive metals, alloys, or any combination thereof.

8. The treatment device of claim 1 wherein the at least one battery is a nano battery.

9. The treatment device of claim 1 wherein the device is used to record neural signals of the peripheral or central nervous system including in healthy and diseased states.

10. The treatment device of claim 1 wherein the device is used to warm fluids.

11. The treatment device of claim 1 wherein biologic information is recorded from the area of use of the treatment device.

12. The treatment device of claim 1 wherein the device is used in conjunction with voltage sensitive dye and associated applications.

13. The treatment device of claim 1 wherein the device is configured to be manipulated by a remote third party or by response to nervous system stimuli such as thought generated responses of movement, action, and the like.

14. The treatment device of claim 1 wherein the device is capable of being used in the implementation of photodynamic antimicrobial chemotherapy in the treatment of wounds and/or infections.

15. A treatment device, comprising:

a therapeutic medium,

wherein the therapeutic medium is configured to produce temperatures covering a range of about −10° C. to about 50° C.;

an applicator connected to the therapeutic medium, the applicator comprising,

an application layer having an application surface and a receiving surface with the application layer being configured to be applied to a skin surface of a user, and a conductive layer having a front side and a back side,

wherein the conductive layer is directly affixed to the receiving surface of the application layer;

a plurality of flexible lighting mechanisms coupled to the application layer;

a power source connected to the therapeutic medium,

wherein the power source is at least one battery; and

a wireless transceiver coupled to the power source and configured to provide bidirectional communication between the treatment device and a secondary electronic device;

a plurality of flexible electrodes integrated with the application layer,

wherein the plurality of flexible electrodes are coupled to the power source providing a mechanism for neuromuscular stimulation in a range of 1 Hz to 160 Hz, and

wherein the plurality of flexible electrodes are comprised of a flexible, conductive polymer;

the plurality of flexible lighting mechanisms being interwoven with fibers of the application layer,

wherein the plurality of flexible lighting mechanisms are configured to emit at least one of red wavelength light and blue wavelength light, and

wherein the plurality of flexible lighting mechanisms have a quantum efficiency of 0.65 to 0.95; and

a control mechanism for changing an operative state of the plurality of flexible lighting mechanisms.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2017
From: ISSEROW, JONATHAN; ISSEROW, LAURA
To: TRANSQTRONICS, LLC.
Reel/Frame 042631/0554 →
Continuity (5)
Continuation In Part 14081110 · Nov 15, 2013
Continuation In Part 13940307 · Jul 12, 2013
Continuation In Part 14106198 · Dec 12, 2013
Continuation In Part 13747584 · Jan 23, 2013
Related Publication 20140206947A1 · Jul 24, 2014
Cited By (10)
US 1,065,551 US 1,084,369 US 1,112,778 US 1,116,120 US 1,141,134 US 1,148,163 US 12,186,513 US 12,295,618 US 12,478,771 US 12,544,051